As our patient was non‐diabetic, his presentation is more accurately described as SGLT2 inhibitor‐induced euglycemic ketosis, a critical differential for metabolic acidosis that falls outside traditional diagnostic guidelines. This evidence concerns the gene SLC5A2 and metabolic acidosis.